This retrospective study examines the effectiveness of combining gemcitabine and carboplatin chemotherapy with or without intravenous vitamin C in patients with advanced triple-negative breast cancer (TNBC). The results suggest that adding vitamin C to chemotherapy may improve treatment outcomes, with patients showing enhanced response rates and potentially reduced side effects.
